These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19164144)

  • 1. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli.
    Al-Hasan MN; Wilson JW; Lahr BD; Thomsen KM; Eckel-Passow JE; Vetter EA; Tleyjeh IM; Baddour LM
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1386-94. PubMed ID: 19164144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
    Ereshefsky BJ; Al-Hasan MN; Gokun Y; Martin CA
    J Chemother; 2017 Feb; 29(1):30-37. PubMed ID: 27376664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.
    Tamma PD; Turnbull AE; Harris AD; Milstone AM; Hsu AJ; Cosgrove SE
    JAMA Pediatr; 2013 Oct; 167(10):903-10. PubMed ID: 23921724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric combination therapy for gram-negative bacteremia.
    Sick AC; Tschudin-Sutter S; Turnbull AE; Weissman SJ; Tamma PD
    Pediatrics; 2014 May; 133(5):e1148-55. PubMed ID: 24709936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.
    Leibovici L; Paul M; Poznanski O; Drucker M; Samra Z; Konigsberger H; Pitlik SD
    Antimicrob Agents Chemother; 1997 May; 41(5):1127-33. PubMed ID: 9145881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral beta-lactam step down in bacteremic E. coli urinary tract infections.
    Saad S; Mina N; Lee C; Afra K
    BMC Infect Dis; 2020 Oct; 20(1):785. PubMed ID: 33087051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical combination of a β-lactam to vancomycin may not improve outcomes of methicillin-susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy.
    Park GE; Ko JH; Cho SY; Ha YE; Lee NY; Kang CI; Chung DR; Song JH; Peck KR
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1091-1096. PubMed ID: 28078559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia?
    Wu PF; Lin YT; Wang FD; Yang TC; Fung CP
    Infection; 2018 Jun; 46(3):365-373. PubMed ID: 29556979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-Infusion β-Lactam Therapy, Mortality, and Subsequent Antibiotic Resistance Among Hospitalized Adults With Gram-Negative Bloodstream Infections.
    Karaba SM; Cosgrove SE; Lee JH; Fiawoo S; Heil EL; Quartuccio KS; Shihadeh KC; Tamma PD
    JAMA Netw Open; 2024 Jul; 7(7):e2418234. PubMed ID: 38954416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
    Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Kollef MH
    Antimicrob Agents Chemother; 2010 May; 54(5):1742-8. PubMed ID: 20160050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
    Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefepime effectiveness in Gram-negative bloodstream infections.
    Al-Hasan MN; Eckel-Passow JE; Baddour LM
    J Antimicrob Chemother; 2011 May; 66(5):1156-60. PubMed ID: 21393128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2005 Feb; 49(2):760-6. PubMed ID: 15673761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis.
    Safdar N; Handelsman J; Maki DG
    Lancet Infect Dis; 2004 Aug; 4(8):519-27. PubMed ID: 15288826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis.
    Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Int J Antimicrob Agents; 2018 Mar; 51(3):488-492. PubMed ID: 28919195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic therapy for gram-negative bacteremia.
    Calandra T; Cometta A
    Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gram-negative bacilli bacteremia: a 7 year retrospective study in a referral Brazilian tertiary-care teaching hospital.
    Quillici MCB; Resende DS; Gonçalves IR; Royer S; Sabino SS; Almeida VF; Ribas RM; Gontijo Filho PP
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258755
    [No Abstract]   [Full Text] [Related]  

  • 19. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
    Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
    Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.
    Koliscak LP; Johnson JW; Beardsley JR; Miller DP; Williamson JC; Luther VP; Ohl CA
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5918-23. PubMed ID: 24041892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.